Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U. Dafni, Olivier Michielin, Silvia Martin Lluesma, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1902-1913
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

Harnessing cytokines and chemokines for cancer therapy
David Propper, Frances R. Balkwill
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 237-253
Closed Access | Times Cited: 613
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 359
Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 225
Promises and challenges of adoptive T-cell therapies for solid tumours
Matteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
British Journal of Cancer (2021) Vol. 124, Iss. 11, pp. 1759-1776
Open Access | Times Cited: 200
From bench to bedside: the history and progress of CAR T cell therapy
Aroshi Mitra, Amrita Barua, Luping Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 184
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
María Ochoa de Olza, Blanca Navarro Rodrigo, Stefan Zimmermann, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 9, pp. e419-e430
Closed Access | Times Cited: 178
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 175
Molecular Markers and Targets in Melanoma
Cristina Teixidó, Paola Castillo, Clara Martínez-Vila, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2320-2320
Open Access | Times Cited: 145
Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy
Hanbing Wang, Baorui Liu, Jia Wei
Cancer Letters (2021) Vol. 517, pp. 96-104
Closed Access | Times Cited: 124
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4160-4160
Open Access | Times Cited: 99
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Mohammad Kazemi, Maryam Sadri, Alireza Najafi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 89
Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis
Hong Sheng Quah, Elaine Yiqun Cao, Lisda Suteja, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 67
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 65
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
Matteo Morotti, Alizée J. Grimm, Helen Carrasco Hope, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 426-434
Open Access | Times Cited: 62
Successes and challenges in clinical gene therapy
Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer
Gene Therapy (2023) Vol. 30, Iss. 10-11, pp. 738-746
Open Access | Times Cited: 61
TIL Therapy: Facts and Hopes
Tine Monberg, Troels Holz Borch, Inge Marie Svane, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 17, pp. 3275-3283
Open Access | Times Cited: 49
Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
Sebastian Klobuch, Tom Seijkens, Ton N. Schumacher, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 173-184
Closed Access | Times Cited: 39
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 + T-myeloid cell networks in melanoma
David Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Science Immunology (2024) Vol. 9, Iss. 92
Open Access | Times Cited: 35
Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances
Hyun Jee Kim, Yeong Ho Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2984-2984
Open Access | Times Cited: 21
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Simon Turcotte, Marco Donia, Brian Gastman, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010207-e010207
Open Access | Times Cited: 2
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
Amrendra Kumar, Reese Watkins, Anna E. Vilgelm
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 96
Evolving impact of long-term survival results on metastatic melanoma treatment
Olivier Michielin, Michael B. Atkins, Henry Koon, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000948-e000948
Open Access | Times Cited: 93
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
Francesco Manfredi, Beatrice Claudia Cianciotti, Alessia Potenza, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 87
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
Jan A. Rath, Caroline Arber
Cells (2020) Vol. 9, Iss. 6, pp. 1485-1485
Open Access | Times Cited: 73
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Samantha J. Seitter, Richard M. Sherry, James Chih‐Hsin Yang, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 19, pp. 5289-5298
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top